Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer

Overview of attention for article published in Value in Health (Elsevier Science), July 2013

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,050 followers.

Cost-effectiveness of the 21-gene assay for guiding adjuvant chemotherapy decisions in early breast cancer. http://t.co/WCdWyAsrDw

Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer http://t.co/PPWzLEO5JR

Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer http://t.co/PPWzLEO5JR

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.